3rd Annual Clinical Trials & Outsourcing Asia Congress

27th February - 28th February 2014 | Shanghai
Oxford Global

3rd Annual Clinical Trials & Outsourcing Asia Congress 2014

Over 150 senior-level international decision makers in Clinical Development, Clinical Trials, Clinical Outsourcing and Clinical Supply Chain from pharma and biotech companies in Asia, the USA and Europe

Over 40 presentations, case studies and panel discussions delivered by leading biotech companies, global pharma organisations & internationally renowned academic institutions

Including 3 interactive streams:

  • Clinical Development Activities & Clinical Research Outsourcing Strategies
  • Biomarkers, Companion Diagnostics & Personalised Medicine
  • Clinical Trials Management Strategies in Asia and Asia Pacific Regions

Co-located with the 4th Annual Pharma R&D World Asia Congress

14 prescheduled one to one meetings, exhibition spaces and informal networking opportunities

Oxford Global Conferences are proud to present the 3rd Annual Clinical Trials & Outsourcing Asia Congress to be held on the 27th & 28th February 2014 in Shanghai, China.

The booming growth of clinical activities in Asia and Asia Pacific regions has advanced the opportunity for business success. Industry leaders believe that the Asian market will overtake the US by 2020. Our conference will offer invaluable insights into: novel clinical development, clinical outsourcing strategies, biomarker clinical research and clinical trial management.

On day one hear from senior experts discussing global and local clinical development strategies. Other topics will include clinical development in oncology and other therapeutic areas, obtaining maximum success from CRO selection and implementing biomarkers into clinical research. Day two will focus on clinical trial management strategies capable of minimising costs, accelerating clinical trial timelines and speeding up drug approval.

Co-located with the 4th Annual Pharma R&D World Asia Congress, the event will bring together over 150 senior level decision makers working within clinical research throughout Asia and Asia Pacific regions.